Validation of L-type calcium channel blocker amlodipine as a novel ADHD treatment through cross-species analysis, drug-target Mendelian randomization, and clinical evidence from medical records
2025 · Neuropsychopharmacology · 11 citations
https://doi.org/10.1038/s41386-025-02062-x